These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 30254642

  • 1. Killing of Latently HIV-Infected CD4 T Cells by Autologous CD8 T Cells Is Modulated by Nef.
    Sevilya Z, Chorin E, Gal-Garber O, Zelinger E, Turner D, Avidor B, Berke G, Hassin D.
    Front Immunol; 2018; 9():2068. PubMed ID: 30254642
    [Abstract] [Full Text] [Related]

  • 2. Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection.
    Fraietta JA, Mueller YM, Yang G, Boesteanu AC, Gracias DT, Do DH, Hope JL, Kathuria N, McGettigan SE, Lewis MG, Giavedoni LD, Jacobson JM, Katsikis PD.
    PLoS Pathog; 2013; 9(10):e1003658. PubMed ID: 24130482
    [Abstract] [Full Text] [Related]

  • 3. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW, Justement JS, Moir S, Hallahan CW, Ehler LA, Liu S, McLaughlin M, Dybul M, Mican JM, Fauci AS.
    Proc Natl Acad Sci U S A; 2001 Jan 02; 98(1):253-8. PubMed ID: 11136258
    [Abstract] [Full Text] [Related]

  • 4. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P, Joos B, Niederöst B, Weber R, Günthard HF, Fischer M.
    J Virol; 2007 Sep 02; 81(18):9693-706. PubMed ID: 17609262
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic HIV-1 Nef blockade promotes CD8 T cell-mediated elimination of latently HIV-1-infected cells in vitro.
    Mujib S, Saiyed A, Fadel S, Bozorgzad A, Aidarus N, Yue FY, Benko E, Kovacs C, Emert-Sedlak LA, Smithgall TE, Ostrowski MA.
    JCI Insight; 2017 Sep 07; 2(17):. PubMed ID: 28878119
    [Abstract] [Full Text] [Related]

  • 6. Nef protein induces differential effects in CD8+ cells from HIV-1-infected patients.
    Silvestris F, Camarda G, Del Prete A, Tucci M, Dammacco F.
    Eur J Clin Invest; 1999 Nov 07; 29(11):980-91. PubMed ID: 10583444
    [Abstract] [Full Text] [Related]

  • 7. Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing.
    Rainho JN, Martins MA, Cunyat F, Watkins IT, Watkins DI, Stevenson M.
    J Virol; 2015 Oct 07; 89(20):10625-36. PubMed ID: 26269172
    [Abstract] [Full Text] [Related]

  • 8. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.
    Lichtenstein KA, Armon C, Nagabhushanam V, Efaw BJ, Frazer-Abel A, Hiserote ME, Alam R.
    Antivir Ther; 2012 Oct 07; 17(7):1301-9. PubMed ID: 22948290
    [Abstract] [Full Text] [Related]

  • 9. Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells.
    Walker-Sperling VE, Cohen VJ, Tarwater PM, Blankson JN.
    J Virol; 2015 Sep 07; 89(18):9631-8. PubMed ID: 26178987
    [Abstract] [Full Text] [Related]

  • 10. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.
    Gahery H, Figueiredo S, Texier C, Pouvelle-Moratille S, Ourth L, Igea C, Surenaud M, Guillet JG, Maillere B.
    AIDS Res Hum Retroviruses; 2007 Mar 07; 23(3):427-37. PubMed ID: 17411376
    [Abstract] [Full Text] [Related]

  • 11. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
    Gahery H, Daniel N, Charmeteau B, Ourth L, Jackson A, Andrieu M, Choppin J, Salmon D, Pialoux G, Guillet JG.
    AIDS Res Hum Retroviruses; 2006 Jul 07; 22(7):684-94. PubMed ID: 16831093
    [Abstract] [Full Text] [Related]

  • 12. Resistance to apoptosis in HIV-infected CD4+ T lymphocytes is mediated by macrophages: role for Nef and immune activation in viral persistence.
    Mahlknecht U, Deng C, Lu MC, Greenough TC, Sullivan JL, O'Brien WA, Herbein G.
    J Immunol; 2000 Dec 01; 165(11):6437-46. PubMed ID: 11086083
    [Abstract] [Full Text] [Related]

  • 13. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists.
    Estaquier J, Tanaka M, Suda T, Nagata S, Golstein P, Ameisen JC.
    Blood; 1996 Jun 15; 87(12):4959-66. PubMed ID: 8652808
    [Abstract] [Full Text] [Related]

  • 14. In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss.
    Watkins RL, Foster JL, Garcia JV.
    Retrovirology; 2015 Jul 14; 12():61. PubMed ID: 26169178
    [Abstract] [Full Text] [Related]

  • 15. Exposure of resting peripheral blood T cells to HIV-1 particles generates CD25+ killer cells in a small subset, leading to induction of apoptosis in bystander cells.
    Kameoka M, Suzuki S, Kimura T, Fujinaga K, Auwanit W, Luftig RB, Ikuta K.
    Int Immunol; 1997 Oct 14; 9(10):1453-62. PubMed ID: 9352350
    [Abstract] [Full Text] [Related]

  • 16. HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.
    Omondi FH, Chandrarathna S, Mujib S, Brumme CJ, Jin SW, Sudderuddin H, Miller RL, Rahimi A, Laeyendecker O, Bonner P, Yue FY, Benko E, Kovacs CM, Brockman MA, Ostrowski M, Brumme ZL.
    J Virol; 2019 Mar 15; 93(6):. PubMed ID: 30602611
    [Abstract] [Full Text] [Related]

  • 17. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
    Fausther-Bovendo H, Sol-Foulon N, Candotti D, Agut H, Schwartz O, Debré P, Vieillard V.
    AIDS; 2009 Jun 01; 23(9):1077-87. PubMed ID: 19424050
    [Abstract] [Full Text] [Related]

  • 18. Modulation of apoptosis and viral latency - an axis to be well understood for successful cure of human immunodeficiency virus.
    Timilsina U, Gaur R.
    J Gen Virol; 2016 Apr 01; 97(4):813-824. PubMed ID: 26764023
    [Abstract] [Full Text] [Related]

  • 19. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
    Olesen R, Vigano S, Rasmussen TA, Søgaard OS, Ouyang Z, Buzon M, Bashirova A, Carrington M, Palmer S, Brinkmann CR, Yu XG, Østergaard L, Tolstrup M, Lichterfeld M.
    J Virol; 2015 Oct 01; 89(20):10176-89. PubMed ID: 26223643
    [Abstract] [Full Text] [Related]

  • 20. Recognition of HIV-1-infected fibrocytes lacking Nef-mediated HLA-B downregulation by HIV-1-specific T cells.
    Kuse N, Noyori O, Takahashi N, Zhang Y, Suzu S, Takiguchi M.
    J Virol; 2024 Jul 23; 98(7):e0079124. PubMed ID: 38940584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.